Paper26907620
Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
Ahn SO and 10 others. J Pharmacol Exp Ther, 2016. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone. Papers, record 26907620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26907620
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzbromarone | Major topic |
| Organic Anion Transporters | Major topic |
| Organic Cation Transport Proteins | Major topic |
| Oxazines | Major topic |
| Pyridines | Major topic |
| Uricosuric Agents | Major topic |
| Animals | |
| Cebus | |
| Chemical and Drug Induced Liver Injury | |
| Dose-Response Relationship, Drug | |
| Female | |
| HEK293 Cells | |
| Humans | |
| Male | |
| Microsomes, Liver | |
| Organic Anion Transport Protein 1 | |
| Organic Anion Transporters, Sodium-Independent | |
| Protein Binding | |
| Uric Acid |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42387087 | Targeted Treatment for Hyperuricemia: The Drug Pipeline. | Drugs Aging | 2026 | https://conductscience.org/library/papers/42387087 | PubMed |
| 41340907 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41340907 | PubMed |
| 41065961 | URAT1 and GLUT9 as drug targets in gout: progress in transporter-directed therapies and delivery technologies. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41065961 | PubMed |
| 40882135 | Gut-kidney axis modulation by viable and inactivated Akkermansia muciniphila mitigates avian hyperuricemia through microbial-metabolic crosstalk. | mSystems | 2025 | https://conductscience.org/library/papers/40882135 | PubMed |
| 40850676 | Serum uric acid and its metabolism-a vital factor in the inflammatory transformation of cancer. | J Adv Res | 2026 | https://conductscience.org/library/papers/40850676 | PubMed |
| 40513003 | Impact of Renal Impairment on the Pharmacodynamic and Pharmacokinetic Profiles of Epaminurad, a Novel Uric Acid Transporter 1 Inhibitor. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/40513003 | PubMed |
| 40420308 | Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study. | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/40420308 | PubMed |
| 39101063 | Binding uric acid: a pure chemical solution for the treatment of hyperuricemia. | RSC Adv | 2024 | https://conductscience.org/library/papers/39101063 | PubMed |
| 38674776 | Priestia megaterium ASC-1 Isolated from Pickled Cabbage Ameliorates Hyperuricemia by Degrading Uric Acid in Rats. | Microorganisms | 2024 | https://conductscience.org/library/papers/38674776 | PubMed |
| 38256226 | Establishment of Polydopamine-Modified HK-2 Cell Membrane Chromatography and Screening of Active Components from Plantago asiatica L. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256226 | PubMed |
| 37959834 | Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors. | Molecules | 2023 | https://conductscience.org/library/papers/37959834 | PubMed |
| 36248735 | Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid. | iScience | 2022 | https://conductscience.org/library/papers/36248735 | PubMed |
| 36081938 | Review of Urate-Lowering Therapeutics: From the Past to the Future. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36081938 | PubMed |
| 34204277 | Modulation of Urate Transport by Drugs. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34204277 | PubMed |
| 33764849 | Limosilactobacillus fermentum JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid. | Gut Microbes | 2021 | https://conductscience.org/library/papers/33764849 | PubMed |
| 32547398 | Identification of Structural Features for the Inhibition of OAT3-Mediated Uptake of Enalaprilat by Selected Drugs and Flavonoids. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32547398 | PubMed |
| 31980978 | Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study. | Clin Exp Nephrol | 2020 | https://conductscience.org/library/papers/31980978 | PubMed |
| 31257523 | Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/31257523 | PubMed |
| 30868332 | Two- and three-dimensional QSAR studies on hURAT1 inhibitors with flexible linkers: topomer CoMFA and HQSAR. | Mol Divers | 2020 | https://conductscience.org/library/papers/30868332 | PubMed |
| 30110943 | Tetragonia tetragonoides (Pall.) Kuntze (New Zealand Spinach) Prevents Obesity and Hyperuricemia in High-Fat Diet-Induced Obese Mice. | Nutrients | 2018 | https://conductscience.org/library/papers/30110943 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SLC22A12 | 116085 | PubTator's text mining | https://conductscience.org/library/genes/116085 | NCBI Gene |
| SLC22A6 | 9356 | PubTator's text mining | https://conductscience.org/library/genes/9356 | NCBI Gene |
| SLC22A8 | 9376 | PubTator's text mining | https://conductscience.org/library/genes/9376 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26907620
GET https://conductscience.org/api/papers/v1/26907620/cited_by?page=2